Innovative Products and Technologies Technology Offers Page 3

Including commercially available innovative products and technologies

DIT Hothouse posted this:

Dublin Institute of Technology (DIT) researchers have invented a unique, patented hologram that changes colour under pressure and has widespread applications for security, authentication and environmental sensing. Holograms are frequently used for security and authentication, and are commonly found on credit cards, bank notes, passports and concert tickets, as well as on a number of high value goods such as pharmaceutical drugs, clothing and accessories. They can also be used as sensors if the hologram is sensitive to changes in its environment, and for tamper detection for document security. Current holographic solutions are usually mass produced from a single master hologram, resulting in identical holograms, with serialisation applied via standard overprinting, allowing the holograms to be either tampered or copied. The pressure-sensitive optical device developed at DIT allows the production of true individual holograms. Specific customer codes can be embedded into the actual hologram during manufacture, making them extremely difficult to copy but very easy for the end user authentication through a pressure-induced colour change of the hologram. The colour change can be either temporary or permanent, depending on specific requirements. This optical device can be a purely visual feature to be used for authentication by the end customer/consumer using thumb pressure, or it can also be designed to be machine readable for automated checking within the supply chain.
New Anti-Counterfeit Technology - Pressure Sensitive Holograms

Yissum - Research Development Company of the Hebrew University posted this:

Cluster11 Project ID : 24-2017-4415
Diagnostic test for epilepsy in Arabian horses

Yissum - Research Development Company of the Hebrew University posted this:

Cluster9 CBD Project ID : 6-2017-4448

Yissum - Research Development Company of the Hebrew University posted this:

Cluster8 Many of the antineoplastic tyrosine kinase inhibitors are associated with prominent and sometimes dose-limiting dermatologic complications. Of severe clinical implication are the specific EGFR inhibitors. Most patients treated with these drugs suffer from severe impairment to their quality of life and require reduction or interruption in the anti-cancer drug protocols. Treatment strategies today for treating skin toxicities from EGFR inhibitors show limited benefit and most patients require dose reductions or interruptions to the anti-cancer treatment protocols. Our proposal focuses on the development of a novel approach using formulation for treating skin toxicities caused by anti-neoplastic EGFR inhibitors by applying topical compounds that specifically and locally block the anti-cancer drugs. Our preliminary results have shown that blocking EGFR inhibitors binding to EGFR prevents keratinocyte death. We have identified small compounds that block EGFR inhibitors binding to its receptor and have developed topical slow release system that can deliver the target compounds to the hair follicle which is a major target for skin rash caused by EGFR inhibitors. Our novel approach will improve the quality of life of patients suffering from skin toxicity and help maintain an optimal anti-neoplastic dose thereby allowing more patients to receive full dose anti-cancer therapy and improve response to therapy Project ID : 6-2017-4450